[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100523788":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":30,"centralContacts":34,"locations":40,"responsibleParty":59,"collaborators":25,"id":61,"slug":62,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":67,"eligibilityCriteria":68,"healthyVolunteers":63,"sex":69,"minAge":70,"maxAge":25,"enrollmentInfo":71,"targetDuration":25,"studyType":74,"phases":75,"briefSummary":77,"conditions":78,"keywords":25,"overallStatus":43,"whyStopped":25,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":89},{"fullName":5,"class":6},"University of Michigan Rogel Cancer Center","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention (Supervised exercise)","EXPERIMENTAL","The individualized program is based on participants' baseline 5-repetition maximum muscular strength assessment and is aligned with current cancer-specific exercise recommendations. The resistance program will follow the FITT principle (frequency, intensity, time, and type):\n\nFrequency. Participants will aim for 3 resistance exercise sessions per week. Intensity. Resistance exercise intensity will have a schedule for increased progression by both load via increased weight and volume via increased repetitions and sets. If participants are not able to increase resistance loads as scheduled, they will remain at their current load and volume until the next scheduled increase.\n\n50% of 5-repetition maximum for upper and lower body. 3 sets of 8 to 12 repetitions.\n\n60% of 5-repetition maximum for upper and lower body. 3 sets of 8 to 12 repetitions.\n\n70% of 5-repetition maximum for upper and lower body. 4 sets of 8 to 12 repetitions.",[13],"Other: Individualized exercise program",{"label":15,"type":16,"description":17,"interventionNames":18},"Control (waitlist)","ACTIVE_COMPARATOR","Participants randomized to the waitlist control condition will be on a waiting list for 24 weeks. Participants in waitlist control condition will complete measures on the same schedule as intervention participants. After 24 weeks, participants will be offered to participate in the online sessions with an exercise trainer using Zoom twice per week for 12- weeks. The sessions will be 30 to 45minutes in length.",[19],"Other: Control Arm",[21,26],{"type":6,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"Individualized exercise program","guided exercise program for 12 weeks",[9],null,{"type":6,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Control Arm","Control Arm Waiting List for 24 weeks, then offered a guided exercise program for 12 weeks",[15],[31],{"name":32,"affiliation":5,"role":33},"Angela Fong, PhD","PRINCIPAL_INVESTIGATOR",[35],{"name":36,"role":37,"phone":38,"phoneExt":25,"email":39},"Cancer AnswerLine","CONTACT","1-800-865-1125","CancerAnswerLine@med.umich.edu",[41],{"facility":42,"status":43,"city":44,"state":45,"zip":46,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"University of Michigan","RECRUITING","Ann Arbor","Michigan","48109","United States","US",{"type":50,"coordinates":51},"Point",[52,53],-83.74088,42.27756,{"lat":53,"lon":52},[56,58],{"name":36,"role":37,"phone":57,"phoneExt":25,"email":39},"800-865-1125",{"name":32,"role":33,"phone":25,"phoneExt":25,"email":25},{"type":60,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100523788","breast-cancer-resiliency-through-exercise-program-b-rep-100523788",false,"NCT06100263","Breast Cancer Resiliency Through Exercise Program (B-REP)","Breast Cancer Resiliency Through Exercise Program (B-REP): Pilot Study","B-REP","Inclusion Criteria:\n\nWomen will be eligible if they meet the following criteria:\n\n* self-identify as Black or African American or Afro-Latina\u002Fe;\n* are ≥18 years old;\n* have a confirmed diagnosis of breast cancer, Stage I to IIIA;\n* have completed primary active treatment (i.e., surgery, chemotherapy, and radiation) within 5 years prior to study start where concomitant hormonal therapy is acceptable;\n* are not meeting current cancer-specific resistance exercise guidelines of ≥ 2 times per week; and\n* are able to speak and understand English.\n\nExclusion Criteria:\n\n* metastatic disease;\n* medical reason that precludes them from increasing current exercise levels;\n* planned elective surgery during study period;\n* pregnant or plans to become pregnant during the study period;\n* plans to move out of United States during the study period; (the rationale for this exclusion is that it will be difficult to conduct the in-person assessments if a participant leaves the United States);\n* current enrollment in another exercise trial; and\u002For\n* inability to pass exercise pre-screening or receive physician consent to increase current physical activity levels.","FEMALE","18 Years",{"count":72,"type":73},75,"ESTIMATED","INTERVENTIONAL",[76],"NA","The study will use a cross-sectional study design with a follow-up 2-arm randomized controlled trial with that has assessments at baseline, post-intervention (i.e., Week 12), and 3-months post-intervention (i.e., Week 24). The 2 arms are the 12-week intervention and waitlist control among 30 Black breast cancer survivors",[79],"Breast Cancer Female","2026-02-05",{"date":82,"type":83},"2026-02-10","ACTUAL",{"date":85,"type":83},"2024-05-28",{"date":87,"type":73},"2026-12",{"name":5,"class":6},1]